FDA raises questions in adcomm briefing docs for Roche's Polivy ... - Endpoints News
An eye, 15 seconds and striking animation: How Horizon's thyroid ... - Endpoints News
Mesoblast's aGVHD cell therapy will get another shot at the FDA - Endpoints News
Net at Work Acquires Innovation ERP, a Leading Sage X3 and Sage 300 Business Consulting Firm - Benzinga
BioMarin seeks label expansion for achondroplasia drug; FDA lifts ... - Endpoints News
FDA Will Not Hold Advisory Meeting for MDD, PPD Drug Application - MD Magazine
Is SAGE Therapeutics Inc (SAGE) Stock at the Top of the Biotechnology Industry? - InvestorsObserver
Is SAGE Therapeutics Inc (SAGE) Stock at the Top of the ... - InvestorsObserver
Makena saga nears an end as Covis requests to pull controversial ... - Endpoints News
Sage Therapeutics shares are trading higher after the company and ... - Benzinga

Pages